A Conjugate of an Anti-Epidermal Growth Factor Receptor (EGFR) VHH and a Cell-Penetrating Peptide Drives Receptor Internalization and Blocks EGFR Activation-Reference-Cited by-同舟云学术

A Conjugate of an Anti-Epidermal Growth Factor Receptor (EGFR) VHH and a Cell-Penetrating Peptide Drives Receptor Internalization and Blocks EGFR Activation

Published:2017-11-07 Issue:24 Volume:18 Page:2390-2394
ISSN:1439-4227
Container-title:ChemBioChem
language:en
Short-container-title:ChemBioChem

Author:

van Lith Sanne A. M.¹^ORCID,van den Brand Dirk²³,Wallbrecher Rike²,van Duijnhoven Sander M. J.¹,Brock Roland²,Leenders William P. J.¹²^ORCID

Affiliation:

1. Radboud University Medical Centre; Department of Pathology; P. O. Box 9101 6500 HB Nijmegen The Netherlands

2. Radboud Institute for Molecular Life Sciences; Department of Biochemistry; Geert-Grooteplein 26 6525 GA Nijmegen The Netherlands

3. Radboud University Medical Centre; Department of Gynecology; P. O. Box 9101 6500 HB Nijmegen The Netherlands

Funder

Radboud Universitair Medisch Centrum

Publisher

Wiley

Subject

Organic Chemistry,Molecular Biology,Molecular Medicine,Biochemistry

Reference47 articles.

1. Targeted Cancer Therapy: The Next Generation of Cancer Treatment

2. ErbB Receptors: Directing Key Signaling Networks Throughout Life

3. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers

4. Epidermal growth factor-related peptides and their receptors in human malignancies

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conditional Cell Penetration of Masked CPPs by an ADEPT-like Approach;ACS Chemical Biology;2024-05-11

2. Molecular and functional insight into anti-EGFR nanobody: Theranostic implications for malignancies;Life Sciences;2024-05

3. Nanobodies in cytokine‑mediated immunotherapy and immunoimaging (Review);International Journal of Molecular Medicine;2023-12-06

4. Site-Specific Antibody Conjugation with Payloads beyond Cytotoxins;Molecules;2023-01-17

5. Conjugation to a cell-penetrating peptide drives the tumour accumulation of the GLP1R antagonist exendin(9-39);European Journal of Nuclear Medicine and Molecular Imaging;2022-11-30